{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/120305"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/120305","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Racial and geographical disparities in medication-assisted treatment completion for individuals with opioid use disorder in the Appalachian region","abstract":"Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2023-09-01 without embargo terms","abstract_html":"Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2023-09-01 without embargo terms","abstract_has_math":false,"creators":["Brown, Diana Elizabeth"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"M.S.","degree_level":"Thesis","degree_discipline":"Community Health","degree_department":null,"school":null,"contributors":["Kang, Hyojung"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-05","date_published":"2023-05","updated_at":"2026-07-22T22:24:57Z","subjects":["Opioid Use Disorder","Appalachia","Medication-assisted Treatment","Racial Disparities","Geographical Disparities","Opioids","Treatment Completion"],"languages":["en","eng"],"rights":["Copyright 2023 Diana Brown"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2142/120305","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Kang, Hyojung"]},{"key":"dc:creator","label":"Author","values":["Brown, Diana Elizabeth"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-05","2023-04-25"]},{"key":"dc:type","label":"Dc Type","values":["text","Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Community Health"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Opioid Use Disorder","Appalachia","Medication-assisted Treatment","Racial Disparities","Geographical Disparities","Opioids","Treatment Completion"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en","eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2023 Diana Brown"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/2142/120305"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2023-09-01 without embargo terms","The student, Diana Brown, accepted the attached license on 2023-04-21 at 10:19.","The student, Diana Brown, submitted this Thesis for approval on 2023-04-21 at 10:33.","This Thesis was approved for publication on 2023-04-25 at 08:53.","DSpace SAF Submission Ingestion Package generated from Vireo submission #19087 on 2023-09-01 at 17:09:17","The opioid crisis is devastating people’s health across the United States, taking their free will and their lives. Through the approval of OxyContin to the mix of fentanyl with other substances, opioids have a stronghold on the American people, affecting any individual who may cross paths with it. In this study, I aimed to highlight the disparities in medication-assisted treatment completion so that future studies can target barriers that these individuals are most affected by in the epidemic. This study employed a national data set, given by SAMHSA, to examine the current landscape of opioid use and treatment completion. Analysis of the sample illuded to necessary research into racial and geographic disparities. Compared to non-Hispanic White individuals, minority individuals have less of a chance of completing treatment across all setting types. Also, individuals who live in states outside of the Appalachian region are almost three times more likely to complete medication-assisted treatment than the individuals who live within the region. This explicitly shows the necessary research into why there are racial disparities and why they continue to persist. Rural America struggles with treatment completion due to a multitude of reasons, including long distances to a treatment facility and provider to patient low ratios. Policy change surrounding treatment providers is necessary to help these affected individuals. Analysis of treatment completion in the detoxification, rehabilitation/residential, and ambulatory settings revealed some consistencies with previous studies and some conflicting results. The results from the variables gender and age presented evidence that is debated by other studies. The variable length of stay showed that the longer an individual remains in treatment, the more of a chance the individual has of completing treatment. Overall, the treatment completion rate across the nation is low. More research is necessary to diminish disparities, especially racial and geographic disparities. The most recent data (2020) should be explored and compared to studies like this one to examine the impact of the Covid-19 pandemic on the landscape of the opioid crisis and response."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Racial and geographical disparities in medication-assisted treatment completion for individuals with opioid use disorder in the Appalachian region"]}]}],"canonical_facts":{"dc:contributor":["Kang, Hyojung"],"dc:creator":["Brown, Diana Elizabeth"],"dc:date":["2023-05","2023-04-25"],"dc:description":["Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2023-09-01 without embargo terms","The student, Diana Brown, accepted the attached license on 2023-04-21 at 10:19.","The student, Diana Brown, submitted this Thesis for approval on 2023-04-21 at 10:33.","This Thesis was approved for publication on 2023-04-25 at 08:53.","DSpace SAF Submission Ingestion Package generated from Vireo submission #19087 on 2023-09-01 at 17:09:17","The opioid crisis is devastating people’s health across the United States, taking their free will and their lives. Through the approval of OxyContin to the mix of fentanyl with other substances, opioids have a stronghold on the American people, affecting any individual who may cross paths with it. In this study, I aimed to highlight the disparities in medication-assisted treatment completion so that future studies can target barriers that these individuals are most affected by in the epidemic. This study employed a national data set, given by SAMHSA, to examine the current landscape of opioid use and treatment completion. Analysis of the sample illuded to necessary research into racial and geographic disparities. Compared to non-Hispanic White individuals, minority individuals have less of a chance of completing treatment across all setting types. Also, individuals who live in states outside of the Appalachian region are almost three times more likely to complete medication-assisted treatment than the individuals who live within the region. This explicitly shows the necessary research into why there are racial disparities and why they continue to persist. Rural America struggles with treatment completion due to a multitude of reasons, including long distances to a treatment facility and provider to patient low ratios. Policy change surrounding treatment providers is necessary to help these affected individuals. Analysis of treatment completion in the detoxification, rehabilitation/residential, and ambulatory settings revealed some consistencies with previous studies and some conflicting results. The results from the variables gender and age presented evidence that is debated by other studies. The variable length of stay showed that the longer an individual remains in treatment, the more of a chance the individual has of completing treatment. Overall, the treatment completion rate across the nation is low. More research is necessary to diminish disparities, especially racial and geographic disparities. The most recent data (2020) should be explored and compared to studies like this one to examine the impact of the Covid-19 pandemic on the landscape of the opioid crisis and response."],"dc:format":["application/pdf"],"dc:identifier":["https://hdl.handle.net/2142/120305"],"dc:language":["en","eng"],"dc:rights":["Copyright 2023 Diana Brown"],"dc:subject":["Opioid Use Disorder","Appalachia","Medication-assisted Treatment","Racial Disparities","Geographical Disparities","Opioids","Treatment Completion"],"dc:title":["Racial and geographical disparities in medication-assisted treatment completion for individuals with opioid use disorder in the Appalachian region"],"dc:type":["text","Thesis"],"thesis:degree_discipline":["Community Health"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.S."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:57Z"}